Download PDFPDF

709 Exosome surface display of IL-12 results in tumor-retained pharmacology with superior potency and limited systemic exposure
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address